Wound healing of intestinal anastomosis after digestive surgery under septic conditions: participation of local interleukin-6 expression.
This study aimed to evaluate the integrity of anastomotic wound healing after digestive surgery under septic conditions and to observe local interleukin-6 (IL-6) expression around the anastomotic segment. Experimental animals were separated into lipopolysaccharide (LPS) and control groups. Each was injected with LPS or normal saline solution into the peritoneal cavity 24 hours before transection and anastomosis of the colon. The anastomotic bursting pressure (ABP) and tissue hydroxyproline concentration (HP) were measured as indicators of wound healing. Immunohistochemical staining for IL-6 was performed on tissue samples obtained from the anastomotic segment, lung, liver, and kidney. The reactive cells were counted by light microscopy. The ABP and HP were significantly lower in the LPS group than the control group 7 days after the surgery. In the LPS group, IL-6 expression around the anastomotic segment was enhanced 1 and 6 hours after surgery but suppressed 24 hours afterward. In contrast, IL-6 expression in lung, liver, and kidney was enhanced in the LPS group 24 hours after surgery but not in the control group. It is suggested that anastomotic wound healing is impaired after digestive tract surgery under septic conditions, and local IL-6 expression participates in wound healing.
Ishimura
K
K
First Department of Surgery, Kagawa Medical University, Japan.
Tsubouchi
T
T
Okano
K
K
Maeba
T
T
Maeta
H
H
D000714:Anastomosis, Surgical; D000818:Animals; D003106:Colon / Q000276:immunology / Q000473:pathology / Q000503:physiopathology / Q000601:surgery*; D004396:Coloring Agents; D004926:Escherichia coli; D005500:Follow-Up Studies; D005786:Gene Expression Regulation; D006909:Hydroxyproline / Q000032:analysis; D007150:Immunohistochemistry; D015850:Interleukin-6 / Q000235:genetics / Q000276:immunology*; D007668:Kidney / Q000276:immunology / Q000473:pathology; D008070:Lipopolysaccharides / Q000009:adverse effects; D008099:Liver / Q000276:immunology / Q000473:pathology; D008168:Lung / Q000276:immunology / Q000473:pathology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D011312:Pressure; D051381:Rats; D017207:Rats, Sprague-Dawley; D018805:Sepsis / Q000150:complications* / Q000276:immunology; D014945:Wound Healing
D004396:Coloring Agents; D015850:Interleukin-6; D008070:Lipopolysaccharides; D006909:Hydroxyproline